- South Africa
- Hong Kong
- New Zealand
- Czech Republic
- United Kingdom
Pfizer believes that providing fast, flexible and innovative supply solutions is entirely compatible with demanding high standards for quality, safety and environmental protection. We are committed to using suppliers that demonstrate strong performance in EHS management.
We seek to ensure that our chemical and biological product suppliers demonstrate strong performance in the management of environment, health and safety risks. For years, we have been providing EHS support to help our suppliers improve their EHS management skills. We also have a long-running program to assess the EHS performance of our suppliers by performing onsite evaluations. The results of these assessments are factored into the supplier selection process. Where improvement is needed, we help suppliers reduce risk with targeted training and coaching, and require action plans that call for timely upgrades of facilities and management systems.
In particular, we aim to:
- Purchase goods and services considering EHS criteria.
- Reduce potential risks of business interruption to our global supply chain.
Notable actions we undertake in supplier reviews include:
- Conducting EHS reviews of our direct suppliers on a routine basis;
- Performing onsite evaluations to assess EHS performance;
- Avoiding new relationships with suppliers that present excessive risk;
- Developing and implementing improvement plans for suppliers that present elevated but manageable risks and who are amenable to implementing timely corrective actions;
- Providing tailored training to current suppliers that demonstrated elevated risk; and
- Conducting subsequent reviews following closure of improvement plans.
Recent performance achievements include:
Pfizer's EHS external supply team completed a total of 213 supplier assessments including pre-contract due diligence in 2011, broken down regionally as follows:
- Asia: 89 (42%)
- Americas: 61 (29%)
- EU/AfME: 63 (29%)
Read more about Pfizer's supplier review program.
Pfizer complies with the California Transparency in Supply Chains Act of 2010 (SB 657) which became effective on January 1, 2012.
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.